High response rate to BNT162b2 mRNA COVID-19 vaccine among self-care dialysis patients
(2021) Clinical Kidney Journal — Vol. 14, n° 9, p. 2129-2131 (2021)
Files
GeorgeryetalHighresponseratetoBNT162b2mRNACOVID-19vaccineamongself-caredialysispatientsCKJ.pdf
Open Access - Adobe PDF
- 346.91 KB
Details
- Authors
- Abstract
- (en) Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is particularly life threatening in patients with kidney failure under dialysis, with mortality rate at 28 days of 21.2% in the ERA-EDTA registry and 25% in the ERACODA (European Renal Association COVID-19 Database) database. [...]
- Affiliations
Citations
Georgery, H., Devresse, A., Yombi, J. C., Belkhir, L., De Greef, J., Scohy, A., Kanaan, N., Kabamba-Mukadi, B., Morelle, J., & Goffin, E. (2021). High response rate to BNT162b2 mRNA COVID-19 vaccine among self-care dialysis patients. Clinical Kidney Journal, 14(9), 2129-2131. https://doi.org/10.1093/ckj/sfab101 (Original work published 2021)